10,323 Shares in Ralliant Corporation $RAL Purchased by First Nebraska Trust Co

First Nebraska Trust Co acquired a new position in shares of Ralliant Corporation (NYSE:RAL) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 10,323 shares of the company’s stock, valued at approximately $760,000.

A number of other large investors also recently added to or reduced their stakes in RAL. BlackRock Inc. bought a new position in shares of Ralliant in the 2nd quarter valued at about $1,039,481,000. Dodge & Cox raised its stake in shares of Ralliant by 13.3% during the fourth quarter. Dodge & Cox now owns 12,214,679 shares of the company’s stock worth $621,849,000 after buying an additional 1,434,376 shares during the last quarter. Viking Global Investors LP acquired a new position in Ralliant in the second quarter valued at approximately $257,200,000. Millennium Management LLC lifted its holdings in Ralliant by 172.4% in the fourth quarter. Millennium Management LLC now owns 4,973,001 shares of the company’s stock valued at $253,175,000 after buying an additional 3,147,660 shares during the period. Finally, State Street Corp acquired a new position in Ralliant in the second quarter valued at approximately $213,096,000.

Ralliant Stock Down 0.3%

Ralliant stock opened at $63.72 on Friday. The firm has a market capitalization of $7.05 billion, a price-to-earnings ratio of -5.87, a PEG ratio of 2.36 and a beta of 1.60. The company’s 50 day simple moving average is $68.94 and its 200 day simple moving average is $55.92. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.52 and a quick ratio of 1.00. Ralliant Corporation has a fifty-two week low of $37.27 and a fifty-two week high of $75.41.

Ralliant (NYSE:RAL) last issued its earnings results on Thursday, July 30th. The company reported $0.68 EPS for the quarter, beating the consensus estimate of $0.63 by $0.05. The firm had revenue of $567.80 million during the quarter. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. As a group, sell-side analysts anticipate that Ralliant Corporation will post 2.87 EPS for the current year.

Ralliant Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 8th. Ralliant’s dividend payout ratio (DPR) is presently -1.84%.

Insider Buying and Selling at Ralliant

In related news, SVP Karen M. Bick sold 6,062 shares of the firm’s stock in a transaction on Monday, August 17th. The stock was sold at an average price of $72.00, for a total transaction of $436,464.00. Following the sale, the senior vice president owned 31,668 shares of the company’s stock, valued at approximately $2,280,096. This trade represents a 16.07% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Tamara S. Newcombe sold 12,936 shares of Ralliant stock in a transaction dated Friday, August 14th. The stock was sold at an average price of $71.79, for a total value of $928,675.44. Following the transaction, the chief executive officer owned 251,967 shares in the company, valued at approximately $18,088,710.93. This represents a 4.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.42% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have commented on RAL. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Ralliant in a report on Friday, July 31st. Royal Bank Of Canada increased their price target on Ralliant from $71.00 to $73.00 and gave the company a “sector perform” rating in a research note on Friday, July 31st. Citigroup raised their price target on Ralliant from $81.00 to $82.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Morgan Stanley lifted their price objective on Ralliant from $68.00 to $85.00 and gave the stock an “overweight” rating in a research note on Tuesday, June 23rd. Finally, Wall Street Zen upgraded Ralliant from a “buy” rating to a “strong-buy” rating in a report on Saturday. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $75.70.

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.